Abdominal Abscess
2
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
1
1
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
2028
GenentechAlteplase
Argon Medical DevicesCatheter Sclerotherapy
Clinical Trials (2)
Total enrollment: 20 patients across 2 trials
Alteplase for Percutaneous Treatment of Loculated Abdominopelvic Abscesses
Start: Feb 2006Est. completion: Oct 200720 patients
Phase 2Completed
Abdominal aBscess Catheter Sclerotherapy (ABCS)
Start: Jul 2026Est. completion: Jul 2028
Phase 1/2Not Yet Recruiting
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space